Ventricular Assist Devices in Advanced-Stage Heart Failure (eBook)

This book focuses on how ventricular assist devices (VADs) can help provide destination therapy for patients with terminal heart failure, one of the most serious diseases in the world today because of the tremendous number of patients, the high mortality rate, and the cost of care. One means of providing cardiological support for patients suffering from heart failure is with VADs, and more than 10,000 patients worldwide have now been implanted with these devices. Half of them already have lived more than one year, and 2,000 patients more than two years, after surgery. This improved survival means that we have reached a point where VADs can be used for destination therapy, not just for bridge-to-recovery or bridge-to-transplant. In view of the increasing number of patients with advanced-stage heart failure and the availability and longevity of transplanted hearts, VADs can solve many problems. In addition to providing information about the devices themselves, this book includes vital guidelines on long-term management and support of VAD-implanted patients' everyday lives.

Kyo Shunei obtained PhD degree in the University of Tokyo Faculty of Medicine, Japan in 1974. Then he worked at Mitsui memorial Hospital as a Resident Surgery till 1980. After serving 2 years at the Department of Surgery of Harvard University as a Research Fellow, he joined the Department of Surgery of Saitama Medical School in 1982 as a lecturer, and promoted to an assistant Professor in 1993, then to a full Professor in 1997, respectively. He has leaded the team members of Department of Therapeutic Strategy for Heart Failure of the University of Tokyo as a Project Professor from 2009. Also, he joined the Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology as an assistant Director in 2011.

---

This book focuses on how ventricular assist devices (VADs) can help provide destination therapy for patients with terminal heart failure, one of the most serious diseases in the world today because of the tremendous number of patients, the high mortality rate, and the cost of care. One means of providing cardiological support for patients suffering from heart failure is with VADs, and more than 10,000 patients worldwide have now been implanted with these devices. Half of them already have lived more than one year, and 2,000 patients more than two years, after surgery. This improved survival means that we have reached a point where VADs can be used for destination therapy, not just for bridge-to-recovery or bridge-to-transplant. In view of the increasing number of patients with advanced-stage heart failure and the availability and longevity of transplanted hearts, VADs can solve many problems. In addition to providing information about the devices themselves, this book includes vital guidelines on long-term management and support of VAD-implanted patients' everyday lives.